Excellent Outcomes in Children and Adolescents with CNS(+) Burkitt Lymphoma or Other Mature B-NHL Using Only Intrathecal and Systemic Chemoimmunotherapy: Results from FAB/LMB96 and COG ANHL01P1

Authors

J. Kimble Frazer
Kevin J. Li
Paul Galardy
Sherrie L. Perkins
Anne Auperin
James Anderson
Mitchell S. Cairo, New York Medical CollegeFollow
Catherine Patte
Mitchell S. Cairo, New York Medical CollegeFollow

DOI

10.1111/bjh.15520

Journal Title

British Journal of Haematology

First Page

374

Last Page

377

Document Type

Letter to the Editor

Publication Date

April 2019

Department

Pediatrics

Keywords

central nervous system, B cell non-Hodgkin lymphoma, Burkitt lymphoma, rituximab

Disciplines

Medicine and Health Sciences

Comments

Please see the work itself for the complete list of authors.

Recommended Citation

Frazer, J., Li, K., Galardy, P., Perkins, S., Auperin, A., Anderson, J., Cairo, M. S., Patte, C., & Cairo, M. (2019). Excellent Outcomes in Children and Adolescents with CNS(+) Burkitt Lymphoma or Other Mature B-NHL Using Only Intrathecal and Systemic Chemoimmunotherapy: Results from FAB/LMB96 and COG ANHL01P1. British Journal of Haematology, 185 (2), 374-377. https://doi.org/10.1111/bjh.15520